Has Covid-19 impacted access to Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 17 September 2020

Prep: Cook: Serves:

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease.

The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors.

The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication.

“Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”

Read more in the study ‘The impact of Covid-19 on access to Parkinson’s disease medication’.

For more information on Parkinson’s and Covid-19 please visit the EPDA website.

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

Last Month

Next Month

Go Back

Share this story

Comments

Health & Fitness

Let’s talk about sex (and Parkinson’s)

How do you deal with sexuality and intimacy in Parkinson's?

“Friendships are more powerful than any border”

Israel-based blogger Debbie Shapiro shares her diary from WPC 2019

Fergus Henderson: a Michelin star recipe for Parkinson’s

The Michelin star chef with Parkinson’s shares a festive three-course mea

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

A new screening tool has been developed to support the early diagnosis of Parkinson’s disease psychosis – a symptom of the condition that is often misdiagnosed. Created by Canadian senior care software company, PointClickCare and membership organisation, the American Society of Consultant Pharmacists (ASCP), the platform asks questions on topics like hallucinations and delusions. Healthcare workers can then review the responses and decide to collect more information and create a care plan. Data collected through the tool will also be used to help scientific research in healthcare organisations. Bill Stuart, clinical product strategist at PointClickCare said: “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s psychosis.” Chad Worz, chief executive of ASCP, added: “We are excited to have another tool for care teams to facilitate a more standardised care process for Parkinson’s disease and we…

Has Covid-19 impacted access to Parkinson’s medication?

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease. The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors. The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication. “Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”

Brazilian dance could improve mobility in people with Parkinson’s, study finds

Researchers at the Federal University of Rio Grande do Sul in Brazil compared participants in a 12-week programme, inspired by samba and forró dances, with those in a walking exercise programme to measure improvement in their functional mobility and gait. The 18 participants had an average age of 68.6 and had all been diagnosed with Parkinson’s over a year ago. The results, published in journal BMC Neurology, found that both groups showed significant improvements in mobility and balance tests. Participants in the dance group showed increases in stride frequency at a self-chosen test speed and a reduced swing time (the amount of time the foot is off the floor) at a fast speed. The results indicated that dance was as “effective as walking in improving functional mobility”. The researchers wrote: “It is essential to find different activities that can offer benefits to individuals… so that they can engage in the…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Has Covid-19 impacted access to Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 17 September 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Health & Fitness

Let’s talk about sex (and Parkinson’s)

Global update

“Friendships are more powerful than any border”

Recipes & Nutrition

Fergus Henderson: a Michelin star recipe for Parkinson’s

New tool could support “faster diagnosis” of Parkinson’s disease psychosis